Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
NDUFS1 encodes the 75-kDa iron–sulfur subunit of mitochondrial complex I, and biallelic loss-of-function or hypomorphic variants cause autosomal recessive mitochondrial disease characterized by multisystem energy failure. Complex I deficiency is a leading cause of mitochondrial disorders, often presenting in infancy with hypotonia, lactic acidosis, neurodevelopmental regression, leukoencephalopathy, and Leigh-like syndromes. Genetic testing by dual genomic sequencing and targeted gene panels has improved diagnostic yield in pediatric cohorts, identifying NDUFS1 among the nuclear‐encoded complex I subunits disrupted in mitochondrial disease.
A total of ≥11 unrelated probands from at least eight families have been reported with biallelic NDUFS1 variants (PMID:11349233, PMID:21203893, PMID:25615419, PMID:20382551). The inheritance mode is autosomal recessive, with segregation demonstrated in consanguineous sibships (two affected siblings segregating the homozygous c.1783A>G (p.Thr595Ala) variant) (PMID:21203893).
The variant spectrum includes missense substitutions (e.g., p.Thr595Ala), nonsense alleles (p.Arg557Ter), frameshift indels (e.g., p.Ile225SerfsTer), splice-site changes, and small in-frame deletions, consistent with loss of enzyme function. A representative pathogenic change is c.1783A>G (p.Thr595Ala) (PMID:21203893).
Functional studies in patient fibroblasts and model organisms show markedly reduced complex I assembly and residual activity, accumulation of reactive oxygen species, and impaired mitochondrial membrane potential. Insertional mutagenesis in Neurospora crassa and galactose-challenge assays in patient cells recapitulate the biochemical phenotype, confirming the deleterious effect of NDUFS1 deficiency (PMID:21203893, PMID:16478720).
Cellular rescue-assays restoring wild-type NDUFS1 expression recover complex I enzyme activity and normalize oxidative stress markers, providing direct causality evidence and supporting potential therapeutic strategies targeting mitochondrial function (PMID:21458341).
Collectively, these genetic and experimental data establish a strong gene–disease relationship between NDUFS1 and autosomal recessive mitochondrial disease. Additional reports continue to expand the allelic and phenotypic spectrum beyond the ClinGen scoring cap.
Key Take-home: Biallelic NDUFS1 variants lead to deficient complex I activity underlying a broad mitochondrial disease phenotype, and functional assays enable definitive molecular diagnosis and inform potential rescue approaches.
Gene–Disease AssociationStrong≥11 unrelated probands, segregation in sibs, concordant functional data Genetic EvidenceStrong11 probands from ≥8 families with biallelic NDUFS1 variants reaching genetic evidence cap Functional EvidenceModerateMultiple fibroblast assays confirm impaired complex I assembly and activity; rescue experiments positive |